Daniel Trencher - 31 May 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF STRATEGY OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
31 May 2024
Transactions value $
-$19,971
Form type
4
Filing time
04 Jun 2024, 16:06:03 UTC
Previous filing
17 May 2024
Next filing
04 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +951 +3.78% 26,143 31 May 2024 Direct F1
transaction TDOC Common Stock Options Exercise +1,179 +4.51% 27,322 31 May 2024 Direct F2
transaction TDOC Common Stock Options Exercise +2,790 +10.21% 30,112 31 May 2024 Direct F2
transaction TDOC Common Stock Sale -$19,971 -1,790 -5.94% $11.16 28,322 03 Jun 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Performance Stock Units Options Exercise $0 -951 -12.5% $0 6,657 31 May 2024 Common Stock 951 Direct F1, F4
transaction TDOC Restricted Stock Units Options Exercise $0 -1,179 -24.99% $0 3,538 31 May 2024 Common Stock 1,179 Direct F2, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -2,790 -12.5% $0 19,532 31 May 2024 Common Stock 2,790 Direct F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 On March 1, 2024, the reporting person earned 11,411 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On March 3, 2023, the reporting person was granted 33,482 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.